Product Description
Technical Specification
- Minimum Order Quantity : 1 Vial
- Shelf life : 1
- Packaging Size : vial
- Prescription/Non prescription : Prescription
- Treatment : cancer
- Manufacturer : glenmark
- Composition : bortezomib
- Brand : Bortrac
Comprehensive Cancer TherapyBortrac 2 mg Bortezomib Injection is formulated as an effective therapeutic option for patients diagnosed with Multiple Myeloma or Mantle Cell Lymphoma. Its precision-targeted action helps inhibit cancer cell growth, making it a trusted choice among oncologists. Administered intravenously or subcutaneously, it offers flexible dosing and can be tailored to a patient's specific needs.
Quality Presentation and Secure PackagingEach Bortrac injection comes as a lyophilized powder in a secure glass vial sealed with a flip-off cap, ensuring product integrity. The medication requires reconstitution with sterile saline, allowing healthcare professionals to prepare a clear, colorless solution ready for safe administration.
Reliable Distribution and StorageBortrac 2 mg is distributed throughout India by Aprazer Healthcare Pvt Ltd and suits the needs of dealers, distributors, importers, and healthcare institutions. The product's one-year shelf life and recommendation to store in a dry place assure proper preservation and efficacy during its use in clinical settings.
FAQ's of Bortrac 2 mg Bortezomib Injection:
Q: How should Bortrac 2 mg Bortezomib Injection be administered?
A: Bortrac 2 mg Bortezomib Injection must be reconstituted with sterile saline and administered either intravenously or subcutaneously by a qualified healthcare professional in a clinical setting.
Q: What conditions is Bortrac 2 mg Bortezomib Injection used to treat?
A: This medication is indicated for patients with Multiple Myeloma and Mantle Cell Lymphoma, where it serves as an effective anti-cancer treatment option.
Q: When should Bortrac 2 mg Bortezomib Injection be used?
A: Bortrac should be used strictly under medical supervision upon a doctor's prescription, following a treatment protocol specific to the patient's cancer diagnosis and stage.
Q: Where should Bortrac 2 mg Injection be stored before use?
A: The vials should be kept in a dry place at the conditions recommended on the label and away from direct sunlight to ensure stability and efficacy.
Q: What is the process for preparing Bortrac 2 mg Injection before administration?
A: A healthcare professional reconstitutes the lyophilized powder with sterile saline to form a clear, colorless solution, which is then administered as prescribed.
Q: What are the benefits of using Bortrac 2 mg Bortezomib Injection?
A: This injection offers a targeted approach to cancer therapy, helping to slow or stop the growth of malignant cells in patients with Multiple Myeloma or Mantle Cell Lymphoma.